Lasse Jensen
CTO
Bioreperia
Sweden
Biography
Lasse founded BioReperia in 2015 together with Anna Fahlgren. Lasse has long experience working with zebrafish and have set up facilities for zebrafish both at Karolinska Institute and Linköping University. In BioReperia, Lasse leads the program on advancing the use of zebrafish embryos for analysis of drug effects in vivo. Lasse has published highly on zebrafish models and are credited with developing several assay systems based on zebrafish embryos used widely for research on toxicology or tumor biology today, including the zebrafish tumor xenograft assay
Research Interest
Biology
